Processa Pharmaceuticals Inc (PCSA) Stock Price, Quote & News

Company Profile

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company's pipeline includes three chemotherapy drugs comprising Gemcitabine, PCS3117 that has completed Phase 2a clinical t...

Industry: Biotechnology

Sector: Healthcare

Phone: 443 776 3133

Fax: 443 288 4420

Website: www.processapharmaceuticals.com

Address:

7380 Coca Cola Drive, Suite 106, Hanover, United States

Shallu Jan. 14 at 4:06 PM

now it's $ROLR , also waiting for $PCSA 🎯

0 · Reply

CelticBeast Jan. 13 at 6:51 PM

$PCSA fuk it I’m in !!! 😏

0 · Reply

TheDrunkTrader69 Jan. 12 at 3:00 PM

$PCSA Bears getting desperate lol, anyone want to waste 2 days of your life, read lawsuit but basically Elion says Processa didnt do their part but they did and have been doing it consistently working with FDA to get PC6442 approved, Processa is sueing Elion for breach of contract and damages. Its ugly and sad but in the end I beleive we are still in the game for a big win. Happy to discuss it but bring proof of what you find i beleive Process will win this plus damages paid or royalties to Elion reduced.

1 · Reply

bigshrug Jan. 10 at 5:17 PM

$PCSA Read the lawsuit documents. Ignore anyone that references the ongoing proceedings without providing specific examples. Buy or sell the stock because YOU think it’s a good idea. Here’s a link: https://iapps.courts.state.ny.us/nyscef/DocumentList?docketId=_PLUS_x9dJAdN3i75zcCYku2KMA==&display=all&courtType=New%20York%20County%20Supreme%20Court&resultsPageNum=1

1 · Reply

Shallu Jan. 9 at 2:37 PM

$PCSA highly rewarding event on the way

0 · Reply

TheDrunkTrader69 Jan. 9 at 1:27 PM

$PCSA Read, this is a 3 week treatment study FDA recommended, so if this goes well we could see some serious action https://www.processapharmaceuticals.com/investors/news-events/press-releases/detail/143/processa-pharmaceuticals-completes-enrollment-of-20th

0 · Reply

TheDrunkTrader69 Jan. 9 at 1:22 PM

$PCSA Just so you know, this stock can take off with no warning, now is buying opportunities, things are getting close enough that big investors will be here very soon. 25 is target this year, Thank me later.

0 · Reply

Tetoooo Jan. 8 at 9:31 PM

$PCSA I like the close today and kind of pin bar candle so I am in again

0 · Reply

Tetoooo Jan. 8 at 2:36 PM

$PCSA without real good news or PR you won’t see a big move. This is just how low float stocks works and hope they won’t dilute anytime soon

1 · Reply

Chilliboy Jan. 8 at 2:04 PM

$PCSA last chance today to get at 3.5 and under, we are going to the moon soon.

0 · Reply

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 9:15 AM EST - 9 days ago

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

Dec 17, 2025, 1:10 PM EST - 27 days ago

Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?

Dec 17, 2025, 8:00 AM EST - 4 weeks ago

Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer

Nov 5, 2025, 9:15 AM EST - 2 months ago

Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025

Aug 7, 2025, 8:30 AM EDT - 5 months ago

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

Jul 1, 2025, 9:00 AM EDT - 7 months ago

Processa Pharmaceuticals Provides Portfolio and Business Update

Jun 17, 2025, 12:26 PM EDT - 7 months ago

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

Jun 17, 2025, 9:00 AM EDT - 7 months ago

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

Jun 13, 2025, 8:00 AM EDT - 7 months ago

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

May 30, 2025, 9:00 AM EDT - 8 months ago

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

Apr 15, 2025, 8:00 AM EDT - 9 months ago

Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025

Mar 18, 2025, 8:30 AM EDT - 10 months ago

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Feb 7, 2025, 8:00 AM EST - 1 year ago

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

Jan 30, 2025, 5:17 PM EST - 1 year ago

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Jan 27, 2025, 8:30 PM EST - 1 year ago

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 2, 2024, 4:05 PM EDT - 1 year ago

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

Jun 11, 2024, 8:20 AM EDT - 1 year ago

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer

May 6, 2024, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Mar 25, 2024, 8:15 AM EDT - 1 year ago

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

Feb 21, 2024, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Feb 14, 2024, 1:00 PM EST - 2 years ago

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

Feb 6, 2024, 8:30 AM EST - 2 years ago

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Feb 1, 2024, 4:22 PM EST - 2 years ago

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

Jan 26, 2024, 9:04 AM EST - 2 years ago

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

Jan 25, 2024, 11:29 AM EST - 2 years ago

What made Processa Pharmaceuticals stock nearly triple on Thursday?

Jan 25, 2024, 8:30 AM EST - 2 years ago

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

Jan 19, 2024, 7:45 AM EST - 2 years ago

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer

Jan 18, 2024, 7:45 AM EST - 2 years ago

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split

Jan 2, 2024, 5:06 PM EST - 2 years ago

Processa Pharmaceuticals to Present at the Biotech Showcase 2024

Dec 19, 2023, 9:00 AM EST - 2 years ago

Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine

Dec 13, 2023, 9:00 AM EST - 2 years ago

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Nov 30, 2023, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals to Present at the MedInvest Oncology Investor Conference

Nov 29, 2023, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook

Nov 13, 2023, 1:40 PM EST - 2 years ago

Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson

Nov 9, 2023, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas

Nov 1, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders

Oct 13, 2023, 1:08 PM EDT - 2 years ago

Processa Pharmaceuticals to Present at the ThinkEquity Conference

Sep 6, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 17, 2023, 8:05 AM EDT - 2 years ago

Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference

Aug 8, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer

Jun 14, 2023, 4:15 PM EDT - 2 years ago

Next Generation Chemotherapy: Improved Treatment for More Patients

May 22, 2023, 8:05 AM EDT - 2 years ago

Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress

May 18, 2023, 8:00 AM EDT - 2 years ago

Processa Pharmaceuticals to Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based on FDA Guidance and Project Optimus Oncology Initiative

Apr 28, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting

Mar 31, 2023, 4:14 PM EDT - 3 years ago

Processa Pharmaceuticals, Inc. (PCSA) Q4 2022 Earnings Call Transcript

Mar 30, 2023, 4:01 PM EDT - 3 years ago

Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results

Shallu Jan. 14 at 4:06 PM

now it's $ROLR , also waiting for $PCSA 🎯

0 · Reply

CelticBeast Jan. 13 at 6:51 PM

$PCSA fuk it I’m in !!! 😏

0 · Reply

TheDrunkTrader69 Jan. 12 at 3:00 PM

1 · Reply

bigshrug Jan. 10 at 5:17 PM

1 · Reply

Shallu Jan. 9 at 2:37 PM

$PCSA highly rewarding event on the way

0 · Reply

TheDrunkTrader69 Jan. 9 at 1:27 PM

0 · Reply

TheDrunkTrader69 Jan. 9 at 1:22 PM

0 · Reply

Tetoooo Jan. 8 at 9:31 PM

$PCSA I like the close today and kind of pin bar candle so I am in again

0 · Reply

Tetoooo Jan. 8 at 2:36 PM

$PCSA without real good news or PR you won’t see a big move. This is just how low float stocks works and hope they won’t dilute anytime soon

1 · Reply

Chilliboy Jan. 8 at 2:04 PM

$PCSA last chance today to get at 3.5 and under, we are going to the moon soon.

0 · Reply

Zing43 Jan. 8 at 11:37 AM

$PCSA what's going on with this one?? Any catalyst coming ahead soon? Thinking of adding.

1 · Reply

JohnTrack Jan. 7 at 9:07 PM

$PCSA on watchlist, sipping coffee...

0 · Reply

TheDrunkTrader69 Jan. 7 at 7:02 PM

$PCSA Quiet before the storm, its out there brewing, enjoy the calm, soon we will have thousands of idiots on here talking about how its gonna drop, right after it takes off to the sky.

0 · Reply

JohnTrack Jan. 7 at 4:26 PM

$PCSA regained compliance with the bid price rule!! https://www.rapidticker.com/news/pcsa-sec-filing-4911dc

1 · Reply

Rampageusa Jan. 7 at 2:20 PM

Watch alert $PCSA 7.5/9.5

0 · Reply

Jwa68 Jan. 7 at 2:14 PM

$PCSA Need some price appreciation to raise capital. Keep an eye on the lawsuit over their main drug...

1 · Reply

Rampageusa Jan. 7 at 1:58 PM

$PCSA,$INBS,$MNTS bullish expect 20% gain from current market price..

0 · Reply

TheDrunkTrader69 Jan. 7 at 1:46 PM

$PCSA Friendly advice, if your buying or adding now is the time. Pressure building and PR due. This will shoot straight up without warning.

1 · Reply

Shallu Jan. 7 at 12:24 PM

$PCSA ✔ Selling pressure is easing ✔ Dips are being bought up faster ✔ Weak hands have left ✔ Stronger owners are staying This is exactly how stocks often behave before the next leg up. Rs Has gone from oversold → neutral → up Not extremely high → there is room to go up This is healthy, not overbought. 🔺 Rising bottoms Relatively flat resistance above Tight range → market waiting for trigger….🙏📈

1 · Reply

IAMHODL Jan. 6 at 10:50 PM

$PCSA my avg is 75$ lol my god

1 · Reply

moneygrabber55 Jan. 6 at 5:47 PM

$PCSA is this halted?

0 · Reply

TheDrunkTrader69 Jan. 6 at 4:45 PM

$PCSA Laugh if you will but im telling you nothing is stopping this once it start get momentum we can go straight to 25.

4 · Reply

Market Cap	7.12M
Revenue (ttm)	0.00
Net Income (ttm)	-11.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	74,200
Avg Vol	972,605
Day's Range	N/A - N/A
Shares Out	2.27M
Stochastic %K	52%
Beta	1.13
Analysts	Sell
Price Target	$25.00